Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.65 is 94% above its 5-year average of -27.17, near the high end of its 5-year range (-66.16–-1.65).
75.75% above its 12-month average of -6.80.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.29.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 37 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.65
EARNINGS PER SHARE (EPS) AVG TTM
-6.80
EARNINGS PER SHARE (EPS) AVG 3Y
-14.48
EARNINGS PER SHARE (EPS) AVG 5Y
-27.17
EARNINGS PER SHARE (EPS) AVG 10Y
-31.66
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+75.75%
CURRENT VS 3Y AVG
+88.60%
CURRENT VS 5Y AVG
+93.93%
CURRENT VS 10Y AVG
+94.79%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Cibus, Inc.
Market Cap
$128.24M
Earnings Per Share (EPS)
-1.65
TTM Avg
-6.80
3Y Avg
-14.48
5Y Avg
-27.17
Market Cap
$129.14M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.25
3Y Avg
-0.32
5Y Avg
-0.38
Market Cap
$125.27M
Earnings Per Share (EPS)
-0.28
TTM Avg
-1.88
3Y Avg
-2.46
5Y Avg
-1.80
Market Cap
$134.74M
Earnings Per Share (EPS)
-0.18
TTM Avg
-0.17
3Y Avg
-0.17
5Y Avg
-0.09
Market Cap
$118.63M
Earnings Per Share (EPS)
N/A
TTM Avg
-5.70
3Y Avg
-9.83
5Y Avg
-0.70
Market Cap
$118.02M
Earnings Per Share (EPS)
-1.08
TTM Avg
-1.62
3Y Avg
-1.56
5Y Avg
-1.43
Market Cap
$117.43M
Earnings Per Share (EPS)
-0.99
TTM Avg
-1.38
3Y Avg
-1.93
5Y Avg
-2.07
Market Cap
$142.11M
Earnings Per Share (EPS)
-1.11
TTM Avg
-1.59
3Y Avg
-2.87
5Y Avg
-3.93
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cibus, Inc. (CBUS) | $128.24M | -1.65 | -6.80 | -14.48 | -27.17 |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | -0.35 | -0.25 | -0.32 | -0.38 |
| enGene Holdings Inc. (ENGN)vs › | $125.27M | -0.28 | -1.88 | -2.46 | -1.80 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | -0.18 | -0.17 | -0.17 | -0.09 |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $118.63M | N/A | -5.70 | -9.83 | -0.70 |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | -1.08 | -1.62 | -1.56 | -1.43 |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | -0.99 | -1.38 | -1.93 | -2.07 |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | -1.11 | -1.59 | -2.87 | -3.93 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $114.24M | -3.21 | -1.79 | -1.14 | -1.14 |
Trailing EPS (TTM)
$-1.65
Forward EPS (Est.)
$-0.85
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.78 |
| 2024-12-31 | -10.83 |
| 2023-12-31 | -25.95 |
| 2022-12-31 | -18.36 |
| 2021-12-31 | -38.96 |
| 2020-12-31 | -66.16 |
| 2019-12-31 | -60.37 |
| 2018-12-31 | -45.46 |
| 2017-12-31 | -46.86 |
| 2016-12-31 | -21.86 |
| 2015-12-31 | -10.65 |
